Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 2 March 2001:
Vol. 291. no. 5509, pp. 1686 - 1688
DOI: 10.1126/science.291.5509.1686
Prev | Table of Contents | Next

News Focus

VIROLOGY:
AIDS Vaccines Show Promise After Years of Frustration

Jon Cohen

CHICAGO, ILLINOIS--The most surprising message from a major international AIDS meeting here last month is that vaccine research is heating up, although many obstacles remain. In session after session, AIDS researchers reported results from novel vaccine experiments that have worked to various degrees in monkeys. They range from clever new ways to make potent antibodies aimed at preventing HIV from infecting cells to new strategies to crank up the so-called cell-mediated arm of the immune system, which clears cells that HIV manages to infect.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Human Immunodeficiency Virus Type 1 Primary Isolate Neutralization Resistance Is Associated with the Syncytium-Inducing Phenotype and Lower CD4 Cell Counts in Subtype CRF01_AE-Infected Patients.
V. R. Polonis, M. S. d. Souza, J. M. Darden, S. Chantakulkij, T. Chuenchitra, S. Nitayaphan, A. E. Brown, M. L. Robb, and D. L. Birx (2003)
J. Virol. 77, 8570-8576
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)